Sonoma Pharmaceuticals

Sonoma Pharmaceuticals is an expert in medical cannabis applications, offering unique and patent-protected treatments for a variety of conditions. They focus on maximizing bioavailability and providing targeted relief for specific ailments. Their innovative drug delivery methods ensure widespread accessibility. Additionally, Sonoma Pharmaceuticals is a global leader in producing stabilized hypochlorous acid (HOCl) products for dermatological conditions, wound care, animal health care, eye care, nasal care, and oral care. They have pioneered the use of HOCl in the specialty pharmaceutical sector, striving to develop safe and effective healthcare solutions for dermatological conditions, eye care, and advanced tissue care. Sonoma Pharmaceuticals has an extensive international presence, collaborating with industry-leading partners in over 50 countries to bring evidence-based, high-quality FDA- and CE-marked products to the market. They are open to engaging potential partners in Europe and North America to expand the reach of their products.